Franklin Resources Inc Codex Dna, Inc. Transaction History

Franklin Resources Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.8 - $6.45 $696,061 - $2.49 Million	-386,701 Reduced 13.98%	2,379,748 $4.28 Million
Q1 2022 May 13, 2022	BUY	$4.12 - $10.36 $7.6 Million - $19.1 Million	1,844,859 Added 200.18%	2,766,449 $14.9 Million
Q4 2021 Feb 11, 2022	BUY	$6.31 - $11.96 $1.19 Million - $2.26 Million	188,690 Added 25.75%	921,590 $9.95 Million
Q3 2021 Nov 12, 2021	BUY	$10.15 - $19.88 $1.86 Million - $3.65 Million	183,700 Added 33.45%	732,900 $8.16 Million
Q2 2021 Aug 13, 2021	BUY	$17.76 - $22.0 $9.75 Million - $12.1 Million	549,200 New	549,200 $12.1 Million

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.